Krka, d. d. (WSE:KRK)

Market Cap	23.25B
Revenue (ttm)	8.17B
Net Income (ttm)	1.53B
Shares Out	n/a
EPS (ttm)	49.62
PE Ratio	15.22
Forward PE	14.56
Dividend	32.10 (4.25%)
Ex-Dividend Date	Jul 23, 2024

Volume	30
Average Volume	78
Open	760.00
Previous Close	756.00
Day's Range	752.00 - 768.00
52-Week Range	534.00 - 776.00
Beta	0.44
RSI	62.68
Earnings Date	May 15, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR